
March 2 (Reuters) - The Centers for Medicare & Medicaid Services has notified Elevance Health ELV.N it plans to impose sanctions that would stop the health insurer from enrolling members in its Medicare Advantage prescription drug plans, a filing showed on Monday.
The sanctions are scheduled to take effect on March 31, 2026, unless the agency determines the issues identified have been satisfactorily addressed.